Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 1/2 2Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 10Carcinoma, Renal Cell 9Kidney Neoplasms 4Stomach Neoplasms 3Mesothelioma 3Lung Neoplasms 3Diabetes Mellitus, Insulin-Dependent, 12 3Carcinoma, Hepatocellular 3Skin Neoplasms 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Various Advanced Cancer 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms 1Melanoma, Cutaneous Malignant 1Lymphatic Metastasis 1

Interventions

cabozantinib 2pembrolizumab 1lenvatinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Clear-cell metastatic renal cell carcinoma × Ipilimumab × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡